section name header

Evidence summaries

Screening for Atrial Fibrillation

Systematic or opportunistic active screening for atrial fibrillation appears to detect additional cases over current practice. Level of evidence: "B"

A Cochrane review[Abstract] 1 included one cluster randomised controlled trial involving 50 general practices in England with a total of 14 829 subjects aged 65 or over. Patients in intervention practices (n=9 866) were randomly allocated to systematic screening (invitation for electrocardiography) or opportunistic screening (pulse taken when they visited their general practitioner for any reason and invitation for electrocardiography if the pulse was irregular). No active screening took place in control practices (n=4 963). Both these screening programmes increased the rate of detection of new cases of atrial fibrillation compared to normal practice (Table T1). Both systematic and opportunistic screening were more effective in men (OR 2.68, 95% CI 1.51 to 4.76 and OR 2.33, 95% CI 1.29 to 4.19, respectively) than in women (OR 0.98, 95% CI 0.59 to 1.62 and OR 1.2, 95% CI 0.74 to 1.93, respectively). No data on the effectiveness of screening in different ethnic or socioeconomic groups were available.

OutcomeParticipants (studies)Assumed - Routine practice*Corresponding - Systematic screening*Relative effectNumber needed to screen
Number of new diagnoses (follow up 12 months)9 075 (1 study)10 per 100016 per 1000 (95 % CI 11 to 23)OR 1.56 (95% CI 1.08 to 2.24)172 (95% CI 94 to 927)
OutcomeParticipants (studies)Routine practice*Opportunistic screening*Relative effectNumber needed to screen
Number of new diagnoses (follow up 12 months)9 088 (1 study)10 per 100016 per 1000 (95% CI 11 to 23)OR 1.57 (95% CI 1.1 to 2.26)167 (95% CI 92 to 806)
*Illustrative comparative number of new diagnoses: assumed - routine practie; corresponding - screening

Uptake of screening was higher for systematic screening than for opportunistic screening, and within both interventions the uptake was higher for men and the 65 to 74 age group compared to people over 75 years. No safety issues or complications were reported. There were insufficient data to compare the effectiveness of screening programmes in different healthcare settings. Systematic screening was more costly than opportunistic screening.

Comment: The quality of evidence is downgraded by study limitations (unclear allocation concealment and lack of blinding).

2024 ESC Guidelines for the management of atrial fibrillation 2 recommends routine heart rhythm assessment during healthcare contact in all individuals aged HASH(0x2fdd378) 65 years old for earlier detection of atrial fibrillation (AF). According to the guideline, in patients HASH(0x2fdd378) 75 years old, or HASH(0x2fdd378) 65 years old with additional CHA2DS2-VA risk factors, population-based screening for AF using a prolonged non-invasive ECG-based approach should be considered.

    References

    • Moran PS, Teljeur C, Ryan M et al. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev 2016;(6):CD009586. [PubMed]
    • Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024;45(36):3314-3414 [PubMed]

Primary/Secondary Keywords